| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2791873 | Best Practice & Research Clinical Endocrinology & Metabolism | 2008 | 8 Pages |
Abstract
Serum thyroglobulin determination plays a central role, in combination with neck ultrasonography, in the follow-up of thyroid cancer patients. Its specificity is improved by thyroid remnant ablation, and its sensitivity is optimal following prolonged withdrawal or stimulation with recombinant human thyroid-stimulating hormone (TSH). Modern methods with an improved functional sensitivity may facilitate its use during follow-up.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Zélia Francis, Martin Schlumberger,